Amgen and Genentech generally came up around the same time. When Genentech went the buyout route with a sale to Swiss drugmaker Roche in 2009, speculation about Amgen’s future followed.

Amgen CEO Bob Bradway stood in Holly Springs last Friday and thanked public officials for making the brand new $500 million drug manufacturing plant behind him a reality.

The past four years have been absolutely phenomenal for Amgen , with its shares tripling in value since the beginning of 2011, inclusive of dividends.

Amgen CEO Robert Bradway scored a 5.8% increase in overall compensation last year mostly thanks to the company’s acquisition of Horizon Therapeutics. For 2023, Amgen granted Bradway $22.6 ...

Amgen and its CEO Robert Bradway were sued for failing to disclose billions of dollars in back taxes and penalties owed to the IRS. By Alexandra Tremayne-Pengelly • 03/15/23 2:25pm.

An Amgen spokesman calls Sharer’s relationship “old news.” For his part, Sharer, who received compensation of $24 million last year, says he prefers to talk about his professional life.

Amgen has been a member of the CEO Roundtable on Cancer since 2014, the same year the company earned Gold Standard Accreditation in the US. Amgen earned Gold Standard accreditation in China in 2017.

Amgen said its experimental weight loss injection helped patients lose up to 20% ... which we will explore in phase three development," Amgen CEO Robert Bradway said on a call with investors ...

For Amgen (NASDAQ: AMGN) , 2017 contained a mix of good news and bad news. Revenue was essentially flat year over year, mainly because of slipping. 5 Things Amgen's CEO Just Said That Investors ...

THOUSAND OAKS, Calif. — George Rathmann, Amgen's founding CEO, has passed away, the drug maker announced Monday. Rathmann, who served as CEO of the company from 1980 to 1988 and board chairman ...